Apparent Formation of Sodium Dodecyl Sulfate-stable Complexes between Serpins and 3,4-Dichloroisocoumarin-inactivated Proteinases Is Due to Regeneration of Active Proteinase from the Inactivated Enzyme*

(Received for publication, December 23, 1996, and in revised form, March 3, 1997)

Steven T. Olson Dagger §, Richard Swanson Dagger , Philip A. Patston and Ingemar Björk par

From the Dagger  Center for Molecular Biology of Oral Diseases and  Department of Oral Medicine and Diagnostic Sciences, University of Illinois, Chicago, Illinois 60612-7213 and the par  Department of Veterinary Medical Chemistry, Swedish University of Agricultural Sciences, Uppsala Biomedical Center, S-751 23 Uppsala, Sweden

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

Protein proteinase inhibitors of the serpin family were recently reported to form SDS-stable complexes with inactive serine proteinases modified at the catalytic serine with 3,4-dichloroisocoumarin (DCI) that resembled the complexes formed with the active enzymes (Christensen, S., Valnickova, Z., Thøgersen, I. B., Pizzo, S. V., Nielsen, H. R., Roepstorff, P., and Enghild, J. J. (1995) J. Biol. Chem. 270, 14859-14862). The discordance between these findings and other reports that similar active site modifications of serine proteinases block the ability of serpins to form SDS-stable complexes prompted us to investigate the mechanism of complex formation between serpins and DCI-inactivated enzymes. Both neutrophil elastase and beta -trypsin inactivated by DCI appeared to form SDS-stable complexes with the serpin, alpha 1-proteinase inhibitor (alpha 1PI), as reported previously. However, several observations suggested that such complex formation resulted from a reaction not with the DCI enzyme but rather with active enzyme regenerated from the DCI enzyme by a rate-limiting hydrolysis reaction. Thus (i) complex formation was blocked by active site-directed peptide chloromethyl ketone inhibitors; (ii) the kinetics of complex formation indicated that the reaction was not second order but rather showed a first-order dependence on DCI enzyme concentration and zero-order dependence on inhibitor concentration; and (iii) complex formation was accompanied by stoichiometric release of a peptide having the sequence SIPPE corresponding to cleavage at the alpha 1PI reactive center P1-P1' bond. Quantitation of kinetic constants for DCI and alpha 1PI inactivation of human neutrophil elastase and trypsin and for reactivation of the DCI enzymes showed that the observed complex formation could be fully accounted for by alpha 1PI preferentially reacting with active enzyme regenerated from DCI enzyme during the reaction. These results support previous findings of the critical importance of the proteinase catalytic serine in the formation of SDS-stable serpin-proteinase complexes and are in accord with an inhibitory mechanism in which the proteinase is trapped at the acyl intermediate stage of proteolysis of the serpin as a substrate.


INTRODUCTION

Serpins comprise a large superfamily of proteins, many of which regulate the activity of serine and, in some cases, also cysteine proteinases in numerous biological processes by functioning as inhibitors of these proteinases (1, 2). Such serpins inhibit their target proteinases by a mechanism that bears similarities to that of other nonserpin families of protein proteinase inhibitors (3, 4). Serpin and nonserpin inhibitors thus both possess an exposed reactive center loop that binds to the active site of their target proteinases in the manner of a substrate. Additionally, both types of inhibitors trap proteinases in stable complexes at an intermediate stage of proteolysis of the inhibitor reactive center loop as a substrate. However, the nature of the trapped complexes distinguishes serpin from nonserpin inhibitors. Serpin-proteinase complexes are thus stable in denaturants such as SDS and guanidinium chloride (5-8), whereas nonserpin inhibitor-proteinase complexes dissociate under such conditions (9). Serpins must further undergo a major conformational change to trap their target proteinases in stable complexes (10-15), whereas nonserpin inhibitors require minimal conformational adjustments to bind their target enzymes (3, 4). Such differences in behavior have suggested that serpins have evolved a novel mechanism for inhibiting proteinases that greatly differs from the mechanism used by nonserpin inhibitors.

While there are no available structures of serpin-proteinase complexes, the SDS stability of these complexes has suggested that serpins may trap proteinases at the tetrahedral or acyl intermediate stage of proteolysis of the serpin as a substrate (2). Early studies favored trapping of the proteinase at the acyl intermediate stage of proteolysis, based on the observation that the serpin reactive center loop was cleaved in the stable complex with proteinase (8, 16-18). However, NMR evidence later suggested that stabilization of the serpin-proteinase complex at the acyl intermediate stage occurred only under denaturing conditions and that under native conditions, the complex was stabilized at the tetrahedral intermediate stage (19). Yet more recent findings have questioned the NMR data by showing that, even under nondenaturing conditions, the reactive center loop is cleaved concomitant with formation of the serpin-proteinase complex, thus supporting an arrest of the serpin-proteinase reaction at the acyl intermediate stage (20-22).

Further controversy has ensued from another recent report that has suggested that the SDS stability of serpin-proteinase complexes does not result from a covalent linkage of the inhibitor to the enzyme active site as would exist in an acyl or tetrahedral intermediate, but rather is due to a covalent cross-linking of the inhibitor with proteinase outside of the enzyme active site (23). The evidence supporting this conclusion included the observations that (i) proteinases blocked at the active site by the inactivating reagent, 3,4-dichloroisocoumarin (DCI),1 appeared still capable of forming SDS-stable complexes with serpins and (ii) no release of the carboxyl-terminal region of the serpin from the complex with proteinase could be demonstrated on denaturation, implying that cleavage of the reactive center loop of the serpin had not occurred. These observations contrast with several earlier studies that showed that the blocking of the proteinase active site with reagents such as diisopropyl fluorophosphate prevented complex formation with serpin inhibitors (5, 7, 24). Even allowing that the DCI reagent is small enough to permit binding of the serpin at the enzyme active site, the results of this study still disagree with other findings with active site-modified serine proteinases, in which minimal modifications of the active site serine to alanine or to dehydroalanine or of the active site histidine to methylhistidine were made. Such catalytically inactive modified enzymes were thus found to be capable of forming only noncovalent complexes with serpins that were dissociable in SDS (7, 9, 25-27). Further, these complexes were of much lower affinity than the SDS-stable complexes formed with active proteinases, consistent with a covalent interaction involving the proteinase catalytic serine residue stabilizing the serpin-proteinase complexes (9).

Because the findings of Christensen et al. (23) are diametrically opposed to previous findings regarding the nature of the stable serpin-proteinase complex, we sought to determine the basis for the discrepancies between these studies by investigating the mechanism by which DCI proteinases form SDS-stable complexes with serpins. While the present study confirms that SDS-stable complexes are formed in the reaction of DCI proteinases with serpins, our reinvestigation of this phenomenon clearly demonstrates that such complexes do not arise from the DCI-inactivated enzyme but rather are formed from active enzyme regenerated from the DCI enzyme. Moreover, evidence is presented that the serpin reactive bond is cleaved in the SDS-stable complexes formed with the DCI enzyme, consistent with the complexes arising from active enzyme and involving a trapping of the enzyme at the acyl intermediate stage of proteolysis.


MATERIALS AND METHODS

Proteins

Bovine trypsin (Type XIII, Sigma) was purified by soybean trypsin inhibitor-agarose affinity chromatography to isolate the single chain beta -form of the enzyme (28). Autolysis of the enzyme was prevented by storage in 1 mM HCl, 10 mM CaCl2. Human neutrophil elastase (HNE) and human alpha 1-proteinase inhibitor (alpha 1PI) were purchased from Athens Research and Technology Inc. (Athens, GA). Alternatively, alpha 1PI was purified from outdated plasma as described (9). beta -Trypsin concentrations were determined from initial rates of hydrolysis of the chromogenic substrate, S-2222 (Pharmacia Hepar, Franklin, OH), by the enzyme using the turnover number measured with active site titrated enzyme (29). Comparison with the concentration measured from the 280-nm absorbance using an absorption coefficient of 36,800 M-1 cm-1 (30) indicated the enzyme was >= 90% active. The concentration of alpha 1PI was determined from the 280-nm absorbance based on an absorption coefficient of 25,400 M-1 cm-1 (31). The inhibitor was fully active based on the 1:1 inhibition stoichiometry (within 10%) measured by titration of beta -trypsin with alpha 1PI (9). HNE concentrations were determined by titration with alpha 1PI assuming an equimolar inhibition stoichiometry.

Experimental Conditions

Trypsin experiments were conducted in 0.1 M Hepes, 0.1% polyethylene glycol 8000, pH 8.0, and HNE experiments were conducted in the same buffer plus 0.5 M NaCl. Temperatures were either 25 or 37 °C as indicated.

Kinetics of DCI Hydrolysis

DCI (Sigma) was dissolved in dimethyl sulfoxide (Me2SO) that had been dried by storage over molecular sieves (Type 4A, Fisher). Hydrolysis reactions were initiated by diluting 0.1 ml of DCI into 0.9 ml of either trypsin or HNE buffers to give final DCI concentrations of 125-250 µM and 10% Me2SO. Hydrolysis was continuously monitored from the decrease in absorbance at 325 nm for several half-lives (32). First-order rate constants were obtained by nonlinear regression fitting of reaction curves by an exponential function with a floating end point. Indistinguishable rate constants were obtained at the two DCI concentrations. DCI concentrations were calculated from the initial 325-nm absorbance using an absorption coefficient of 3330 M-1 cm-1 (32).

Kinetics of Trypsin or HNE Inhibition by DCI or Chloromethyl Ketones

The kinetics of enzyme inhibition were measured under pseudo first-order conditions either by discontinuous or continuous assay methods (33). For the discontinuous assay method, reactions contained 10 nM enzyme and either 125-250 µM DCI, 100-200 nM Phe-Phe-Arg chloromethyl ketone (Calbiochem), or 5 µM methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone (Bachem, King of Prussia, PA) in 0.1 ml. Identical reaction samples were quenched at various times with 0.9 ml of chromogenic substrate, and residual enzyme activity was measured from the initial rate of substrate hydrolysis at 405 nm. The substrates were 200 µM methoxysuccinyl-Ala-Ala-Pro-Val p-nitroanilide (Calbiochem) for HNE and 200 µM S-2222 for trypsin. For reactions of 4-10 µM trypsin with 250 µM DCI at 25 °C, samples of the reaction mixture were first quenched at different times into 4 mM HCl, 10 mM CaCl2 (40-fold dilution) and then further diluted 100-fold into substrate for activity determination. Pseudo first-order rate constants (kobs) were determined by nonlinear regression fitting of the loss of enzyme activity to an exponential decay function. Second-order rate constants were obtained by dividing kobs by the inhibitor concentration. For the continuous assay, DCI and then HNE were added in rapid succession to chromogenic substrate to give final concentrations of 20 nM HNE, 2.5-10 µM DCI, and 320 µM substrate. The exponential decrease in substrate hydrolysis rate was monitored continuously for up to 5 min to an end point rate (<2% of the initial rate) with <5% consumption of substrate. Progress curves were fit by nonlinear regression to an exponential plus linear term (33, 34) to obtain kobs. kobs was corrected for substrate competition by multiplying by the factor, 1 + [S]0/Km, where [S]0 is the substrate concentration. Km was measured to be 46 ± 9 µM at 25 °C and 52 ± 4 µM at 37 °C (±2 S.E.). Second-order rate constants were obtained by dividing the corrected kobs by the inhibitor concentration. The final concentration of Me2SO was 10% in all DCI enzyme reactions. No correction for hydrolysis of DCI was made in any of these reactions, since the extent of such hydrolysis was found to be negligible over the time course of the reactions studied.

Kinetics of alpha 1PI Inhibition of Trypsin and HNE

The kinetics of inhibition of proteinases by alpha 1PI were measured under pseudo first-order conditions either by discontinuous (trypsin) or continuous (HNE) assays. Trypsin reactions contained 2.5 nM enzyme and 25 or 50 nM alpha 1PI in 0.1 ml. At different times, reactions were quenched by adding 0.9 ml of 200 µM S-2222 substrate, and residual enzyme activity was measured from the initial substrate hydrolysis rate at 405 nm. kobs was determined by nonlinear regression fits to an exponential decay function. HNE reactions contained 1.25-5 nM alpha 1PI, 0.25-1 nM HNE, and 330 µM substrate and were initiated with enzyme. The exponential decrease in substrate hydrolysis rate was monitored continuously until an end point rate was reached (<1% of the initial rate) during which <1% substrate was consumed. Progress curves were fit by an exponential plus linear function to obtain kobs, and second-order rate constants were obtained from corrected values of kobs, as described for DCI HNE reactions.

Kinetics of Regeneration of Active Enzyme from DCI Enzyme by Hydrolysis

DCI enzyme was prepared by incubating 250 µM DCI with 6 µM enzyme for 15 min at 25 °C (final Me2SO concentration, 10%). After diluting the inactivated enzyme 20-fold, excess DCI was removed by dialysis at 4 °C for 3 h against 100 volumes of reaction buffer containing 4-5% Me2SO (to mimic the conditions for alpha 1PI complex formation in SDS gel electrophoresis experiments) with buffer changes after each hour. A control enzyme sample was treated similarly except that no DCI was added. A 50-µl aliquot containing 47-140 nM DCI HNE or 5-16 nM DCI trypsin was then added to 0.95 ml of 200 µM substrate in buffer containing 4-5% Me2SO, and the accelerating rate of substrate hydrolysis was monitored continuously at 405 nm for 15 min at 37 °C (<= 5% substrate hydrolysis). Data were fit by nonlinear regression by the parabolic equation (33),
A<SUB>t</SUB>=A<SUB>0</SUB>+v<SUB>0</SUB>t+<FR><NU>k<SUB><UP>hyd</UP></SUB> [E-<UP>I</UP>]<SUB>0</SUB> <UP>TN</UP></NU><DE>2</DE></FR> t<SUP>2</SUP>
where A0 and At are the absorbance at zero time and time t, respectively, v0 is the initial rate of absorbance change, khyd is the first-order rate constant for hydrolysis of the DCI enzyme, [E-I]0 is the concentration of DCI enzyme at zero time, and TN is the turnover number for enzyme hydrolysis of the substrate under the conditions of the experiment, expressed as the rate of absorbance change/unit of enzyme concentration. khyd was calculated from the fitted coefficient of the t2 term using the independently measured turnover number and concentration of DCI enzyme. The latter was determined from the enzyme activity generated after complete hydrolysis of the DCI enzyme in buffer containing 0.5 M NH2OH for ~20 h at 25 °C (32). Concentrations of regenerated enzyme were indistinguishable from those of control enzyme samples not reacted with DCI with or without hydroxylamine treatment.

SDS-Polyacrylamide Gel Electrophoresis and Western Blotting

Reactions of alpha 1PI with active and DCI-inactivated enzymes followed the protocol of Christensen et al. (23). DCI enzymes were prepared by incubating enzyme with 250 µM DCI for 15 min at 25 °C (final Me2SO concentration, 10%). An equal volume of alpha 1PI or alpha 1PI plus Phe-Phe-Arg chloromethyl ketone or methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone at 37 °C was then added in a single aliquot, and the incubation was continued at 37 °C for 30 min. Reactions were then quenched by first adding either 500 µM Phe-Phe-Arg chloromethyl ketone (trypsin) or 250 µM DCI (HNE) to avoid nonspecific proteolysis during denaturation followed by addition of SDS and then boiling for 3 min before electrophoresis on 10% gels according to Laemmli (35). For experiments designed to detect a carboxyl-terminal peptide formed concomitant with the alpha 1PI-proteinase complex, a Tricine-step gel system was used, in which the lower half of the gel was 16.5% acrylamide and the upper half was 10% acrylamide (36). Bands were stained with Coomassie Brilliant Blue R-250 and quantified by scanning the gels in an UltroScan XL laser densitometer (Pharmacia-LKB Biotechnology, Uppsala, Sweden). For the quantitation of serpin-proteinase complex formation in alpha 1PI reactions with DCI enzymes, the amount of complex formed in the reaction with active enzyme was taken as 100%. A series of dilutions of this maximum level of complex indicated a linear relationship between the amount of complex and the integrated band intensity. For Western blotting detection of alpha 1PI·HNE complexes formed at lower serpin and proteinase concentrations, proteins electrophoresed on 10% SDS gels were transferred to nitrocellulose membranes (37), and inhibitor bands were then detected by incubating with sheep anti-alpha 1PI Ig followed by donkey anti-sheep IgG conjugated with alkaline phosphatase (Binding Site, Inc., San Diego, CA) and then 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium substrate (Sigma).

Peptide Sequencing

After SDS-Tricine step polyacrylamide gel electrophoresis to separate the carboxyl-terminal peptide as described above, the unstained gel was electroblotted to a polyvinylidene difluoride membrane (Qiabrane PVDF, Qiagen, Chatsworth, CA). The membrane was stained with Coomassie Brilliant Blue R-250, the appropriate band was excised, and the peptide was sequenced directly in an Applied Biosystems (Foster City, CA) 470A gas phase sequencer connected on line to a 120A phenylthiohydantoin analyzer.


RESULTS AND DISCUSSION

In the reaction of DCI trypsin with alpha 1PI, an SDS-stable complex was formed that was indistinguishable from the complex formed with active trypsin, in agreement with the report of Christensen et al. (23) (Fig. 1). However, as also observed in the previous report, the amount of complex formed when DCI trypsin was reacted with equimolar alpha 1PI for 30 min at 37 °C was considerably less than that formed with active trypsin under identical conditions (Fig. 1, lanes 4 and 7). Doubling the concentration of DCI enzyme in the reaction doubled the amount of complex, whereas varying the alpha 1PI concentration from 0.5 to 2 times the molar concentration of DCI enzyme produced the same amount of complex as that formed at equimolar concentrations (Fig. 1, lanes 7-9). The extent of complex formation at equimolar DCI enzyme and inhibitor also progressively increased with increasing time of incubation (Fig. 2, lanes 4-6). Integrating the intensity of the complex bands in a separate experiment revealed that 14, 25, and 39% of the complex produced with active enzyme was formed in the reaction with the DCI enzyme after 30, 60, and 120 min, respectively. Together, these observations indicated that the formation of a stable complex from DCI enzyme and alpha 1PI was limited by a reaction that was first order in DCI enzyme concentration but zero order in inhibitor concentration. This contrasts with the alpha 1PI reaction with active trypsin, which is first order in both enzyme and inhibitor concentrations, i.e. second order overall.


Fig. 1. Formation of SDS-stable complexes in the reactions of alpha 1PI with trypsin and with DCI trypsin analyzed by SDS-polyacrylamide gel electrophoresis. Reactions of alpha 1PI with trypsin (lanes 3-5) or with DCI trypsin (lanes 6-9) in the presence or absence of Phe-Phe-Arg chloromethyl ketone were for 5 min at 25 °C in the case of the active enzyme and for 30 min at 37 °C in the case of the DCI enzyme. DCI trypsin was prepared immediately before the reaction with inhibitor by incubating 10 µM trypsin with 250 µM DCI for 15 min at 25 °C. Other details are given under "Materials and Methods." Lane 1, 5 µM trypsin alone; lane 2, 5 µM alpha 1PI alone; lane 3, 2.5 µM trypsin plus 2.5 µM alpha 1PI; lane 4, 5 µM trypsin plus 5 µM alpha 1PI; lane 5, as lane 4 plus 340 µM Phe-Phe-Arg chloromethyl ketone; lane 6, 5 µM DCI trypsin; lane 7, 5 µM DCI trypsin plus 5 µM alpha 1PI; lane 8, 10 µM DCI trypsin plus 5 µM alpha 1PI; lane 9, 5 µM DCI trypsin plus 10 µM alpha 1PI; lane 10, as lane 8 plus 340 µM Phe-Phe-Arg chloromethyl ketone.
[View Larger Version of this Image (48K GIF file)]


Fig. 2. Demonstration by SDS-Tricine step polyacrylamide gel electrophoresis of peptide release concomitant with the reactions of alpha 1PI with active or DCI-inactivated proteinases. Reactions of 9.7 µM alpha 1PI with equimolar active or DCI-inactivated trypsin and HNE were conducted as in Figs. 1 and 3 except that some reaction times were varied as noted. Lane 1, alpha 1PI alone; lane 2, trypsin alone; lane 3, alpha 1PI plus trypsin reacted for 5 min; lane 4, alpha 1PI plus DCI trypsin reacted for 30 min; lane 5, same as lane 4 except that reaction was for 60 min; lane 6, same as lane 4 except that reaction was for 120 min; lane 7, alpha 1PI plus DCI HNE reacted for 30 min; lane 8, alpha 1PI plus HNE reacted for 5 min; lane 9, HNE alone; lane 10, molecular mass standards in kDa: 37, 29, 18, 9, and 4.4.
[View Larger Version of this Image (57K GIF file)]

To assess whether the SDS-stable complexes formed with alpha 1PI and DCI trypsin involved a covalent interaction between the enzyme and inhibitor outside the enzyme active site rather than within the active site, we tested the effect of an efficient active site-directed inhibitor, D-Phe-Phe-Arg chloromethyl ketone, on SDS-stable complex formation. Addition of chloromethyl ketone together with alpha 1PI resulted in a nearly complete blocking of the reaction of alpha 1PI with both active trypsin and inactive DCI trypsin (Fig. 1, lanes 5 and 10). Such results suggested that the complex formed in the reaction of DCI enzyme with alpha 1PI might be arising from active enzyme generated during the reaction by hydrolysis of the DCI inactivating group rather than from the DCI enzyme itself.

To investigate this possibility, the kinetics of trypsin inactivation by DCI and reactivation of DCI trypsin were analyzed under the conditions used for observing SDS-stable complex formation between alpha 1PI and DCI trypsin in the report of Christensen et al. (23). The enzyme (4-10 µM) was inactivated by 250 µM DCI at 25 °C in a first-order process (t1/2 ~30 s), with less than 1% residual activity remaining after the 15-min incubation previously used to prepare the DCI enzyme. The second-order rate constant determined from inactivation progress curves over a range of inhibitor concentrations and under pseudo first-order conditions was about 2-fold lower than the value originally reported for this reaction by Harper et al. (32) at lower pH and higher ionic strength (Table I). Although trypsin appeared to be essentially all inactivated by DCI, DCI enzymes are known to slowly regenerate active enzyme by hydrolysis of the active site blocking reagent (32). Such regeneration of trypsin from DCI trypsin was measured by diluting the DCI enzyme into a reporter chromogenic substrate after dialysis to remove excess DCI and monitoring the acceleration of the substrate hydrolysis rate. A first-order rate constant of 8.1 ± 0.6 × 10-5 s-1 was determined for release of active enzyme under the conditions used for complex formation with alpha 1PI, i.e. 37 °C. Based on this rate constant, the amount of reactivated trypsin formed was predicted to be 14 ± 1% during the 30-min time interval allowed for reaction of DCI trypsin with alpha 1PI in Figs. 1 and 2, similar to the 13-15% complex observed by integrating the intensity of the complex bands. This observation was in keeping with the expectation that any trypsin regenerated from DCI trypsin would exclusively react with alpha 1PI at the concentrations of serpin and DCI present during the reaction, given the ~5000-fold faster second-order rate constant measured for inhibition of trypsin by alpha 1PI than by DCI and the depletion of DCI by hydrolysis during the formation of the DCI enzyme (Table I and Scheme 1). The ability to block the reaction of regenerated trypsin with alpha 1PI by Phe-Phe-Arg chloromethyl ketone was also consistent with the relative inhibition rate constants and concentrations of serpin and chloromethyl ketone employed in the reaction (Table I).

Table I. Kinetic constants for reactions of active and DCI-inactivated enzymes

The kinetics of the reactions depicted in the left-hand column (where E denotes enzyme, CK denotes chloromethyl ketone, and DCI* represents the hydrolysis product of DCI) were measured at the indicated temperatures either in 0.1 M Hepes, 0.1% polyethylene glycol 8000, pH 8.0, for trypsin reactions or in 0.1 M Hepes, 0.5 M NaCl, 0.1% polyethylene glycol 8000, pH 8.0, for HNE reactions, as described under "Materials and Methods." Errors represent either the range of at least two determinations or ±2 S.E. ND, not determined. The kinetics of the reactions depicted in the left-hand column (where E denotes enzyme, CK denotes chloromethyl ketone, and DCI* represents the hydrolysis product of DCI) were measured at the indicated temperatures either in 0.1 M Hepes, 0.1% polyethylene glycol 8000, pH 8.0, for trypsin reactions or in 0.1 M Hepes, 0.5 M NaCl, 0.1% polyethylene glycol 8000, pH 8.0, for HNE reactions, as described under "Materials and Methods." Errors represent either the range of at least two determinations or ±2 S.E. ND, not determined.

Trypsin
HNE
25 °C 37 °C 25 °C 37 °C

(M-1 s-1 or s-1) (M-1 s-1 or s-1)
E + DCI right-arrow E-DCI 9.5  ± 0.4 × 101 2.0  ± 0.1 × 102 4.3  ± 0.4 × 104 7.2  ± 0.2 × 104
E + alpha 1PI right-arrow E-alpha 1PI 4.9  ± 0.1 × 105 8.9  ± 1.6 × 105 9.5  ± 0.6 × 106 1.4  ± 0.1 × 107
E + CK right-arrow E-CKa ND 8.4  ± 0.3 × 104 ND 7.1  ± 0.1 × 103
E-DCI right-arrow E + DCI*b ND 8.1  ± 0.6 × 10-5 ND 1.4  ± 0.1 × 10-4
DCI + H2O right-arrow DCI*c 6.1  ± 0.1 × 10-4 1.4  ± 0.1 × 10-3 4.7  ± 0.1 × 10-4 1.1  ± 0.1 × 10-3

a Reaction of enzymes with either Phe-Phe-Arg chloromethyl ketone for trypsin or methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone for HNE.
b Determined in buffer containing 4% Me2SO for the HNE reaction and 5% Me2SO for the trypsin reaction.
c Pseudo first-order rate constant for hydrolysis of DCI measured either in trypsin or HNE buffers.


Fig. S1. kalpha 1PI >>  kDCI
[View Larger Version of this Image (7K GIF file)]

The above observations indicated that the amount of SDS-stable complex formed in the reaction of alpha 1PI with DCI trypsin could be fully accounted for by the amount of active trypsin regenerated from DCI trypsin by a rate-limiting hydrolysis of the inactivated enzyme (Scheme 1). Such an interpretation was consistent with the first-order dependence of complex formation on the DCI enzyme concentration, the independence on the alpha 1PI concentration, and the dependence of the amount of complex formed on the time of incubation of DCI trypsin with alpha 1PI. In keeping with this conclusion, a ~5-kDa peptide appeared concomitant with the formation of the SDS-stable complex in the reactions of alpha 1PI with both DCI trypsin and trypsin (Fig. 2, lanes 3-6). The amount of peptide generated was stoichiometric with the amount of complex, based on the similar ratios of the integrated intensities of peptide to complex bands for active and inactive enzyme reactions. Amino-terminal sequencing of the peptide produced in the DCI trypsin reaction gave the sequence SIPPE corresponding to cleavage of alpha 1PI in the reactive center Met358-Ser359 P1-P1' bond in the stable complex. Such cleavage is known to accompany the reaction of alpha 1PI with active proteinases (16, 20, 21) and indicates that the SDS-stable complexes formed between alpha 1PI and DCI trypsin or trypsin both result from a reaction of the serpin with active trypsin.

Our finding of the stoichiometric release of a carboxyl-terminal peptide from the enzyme-serpin complex resulting from cleavage at the serpin reactive bond argues against suggestions by Christensen et al. (23) that the carboxyl terminus of the serpin in SDS-stable alpha 1PI-enzyme complexes is intact. The failure to observe this peptide in the previous work may have been due to the loss or reduced visibility of the ~5-kDa peptide in the SDS gradient gel system employed. By increasing the amount of protein loaded on the gel and calibrating the gel with standard peptides, the ~5-kDa peptide was clearly visible in our gel system. The cleavage and release of homologous carboxyl-terminal peptides from other SDS-stable serpin-proteinase complexes have been convincingly shown in numerous other studies (8, 16, 18, 20-22, 38).

Similar experiments comparing the reactions of alpha 1PI with HNE and DCI HNE showed that the DCI enzyme formed 18 ± 2% of the SDS-stable complex generated in the reaction of equimolar alpha 1PI with active enzyme (Fig. 3, top panel, lanes 3 and 6). The DCI HNE reaction showed a similar first-order dependence of stable complex formation on the concentration of DCI enzyme, independence of inhibitor concentration, and dependence on the time of reaction, as the DCI trypsin reaction (Fig. 3, top panel, lanes 6-8). Measurement of the rate constants for the inactivation of HNE by DCI and alpha 1PI and for the regeneration of HNE from DCI HNE (Table I) predicted that 22 ± 2% of the stable complex should result from the regeneration of active HNE during the 30-min reaction with alpha 1PI, in good agreement with the amount observed. Addition of an HNE-specific tetrapeptide chloromethyl ketone reagent (2 mM methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone) together with alpha 1PI was not as effective in blocking complex formation with the DCI enzyme in this case (Fig. 3, top panel, lanes 4 and 9). This could be explained by the chloromethyl ketone not being an effective competitor of alpha 1PI at the concentrations employed, based on measured rate constants for these two inhibitors (Table I). Consistent with this explanation, lowering the inhibitor and DCI enzyme concentrations in the reaction by 5-fold but maintaining the chloromethyl ketone concentration to reduce the competitive advantage of alpha 1PI resulted in the ability of the chloromethyl ketone to significantly block SDS-stable complex formation, as revealed by Western blotting (Fig. 3, bottom panel). The SDS-stable complex formed in the reaction of alpha 1PI with DCI HNE was also accompanied by the liberation of the same ~5-kDa peptide observed in the reaction of the serpin with DCI trypsin, suggesting that the alpha 1PI reactive center was similarly cleaved in this complex (Fig. 2, lanes 7 and 8). Together, these observations provide additional evidence that the SDS-stable serpin-enzyme complexes formed in the reactions of alpha 1PI with either DCI HNE or DCI trypsin arise from a reaction of the serpin with active enzyme generated from the inactive enzyme by spontaneous hydrolysis (Scheme 1). Complex formation between DCI enzymes and serpins reported in another study may similarly have resulted from regeneration of active enzyme (39).


Fig. 3. Formation of SDS-stable complexes in the reactions of alpha 1PI with HNE and with DCI HNE analyzed by SDS-polyacrylamide gel electrophoresis and Western blotting. Reactions of alpha 1PI with HNE or with DCI HNE in the presence or absence of methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone were for 5 min at 25 °C in the case of active enzyme and for 30 min at 37 °C in the case of DCI enzyme. DCI HNE was prepared immediately before the reaction with inhibitor by incubating 3.8 µM HNE with 250 µM DCI. Further details are given under "Materials and Methods." Top, SDS-polyacrylamide gel electrophoresis of HNE reactions. Lane 1, 1 µM HNE alone; lane 2, 1 µM alpha 1PI alone; lane 3, 1 µM alpha 1PI plus 1 µM HNE; lane 4, as lane 3 plus 2 mM chloromethyl ketone; lane 5, 1 µM DCI HNE alone; lane 6, 1 µM alpha 1PI plus 1 µM DCI HNE; lane 7, 1 µM alpha 1PI plus 2 µM DCI HNE; lane 8, 2 µM alpha 1PI plus 1 µM DCI HNE; lane 9, as lane 7 plus 2 mM chloromethyl ketone; lane 10, molecular mass standards in kDa: 94, 67, 43, 30, and 20. Bottom, Western blot of HNE reactions. Lane 1, 0.2 µM alpha 1PI alone; lane 2, 0.2 µM alpha 1PI plus 0.2 µM HNE; lane 3, as lane 2 plus 2 mM chloromethyl ketone; lane 4, 0.2 µM DCI HNE alone; lane 5, 0.2 µM alpha 1PI plus 0.2 µM DCI HNE; lane 6, 0.4 µM alpha 1PI plus 0.2 µM DCI HNE; lane 7, 0.2 µM alpha 1PI plus 0.4 µM DCI HNE; lane 8, as lane 5 plus 2 mM chloromethyl ketone; lane 9, as lane 7 plus 2 mM chloromethyl ketone; lane 10, 0.2 µM alpha 1PI alone.
[View Larger Version of this Image (86K GIF file)]

The present findings argue strongly against the conclusion made by Christensen et al. (23) that serpins can form SDS-stable complexes with proteinases that lack a functional catalytic apparatus. Several early studies clearly showed that blocking of the active site of proteinases by bulky reagents such as diisopropyl fluorophosphate prevents complex formation with serpin inhibitors (5, 7, 24). Subsequent studies in which inactivating modifications of the catalytic serine or histidine residues were made without introducing bulky groups into the active site, i.e. by converting the serine to dehydroalanine or alanine or by methylating the histidine, were also found to prevent SDS-stable complex formation with serpins. However, such active site-modified enzymes were capable of forming noncovalent complexes with serpin inhibitors (7, 9, 25-27). Significantly, the affinity of these noncovalent complexes was found to be at least 4-6 orders of magnitude weaker than that of the covalent complexes formed between the same serpins and the active proteinase (9). The observation that methylation of the active site histidine resulted in much weaker noncovalent complexes than the serine modifications (26) also implies that the DCI-inactivating group is most likely too large to allow DCI-inactivated enzymes to make any significant noncovalent interaction with serpins.

In summary, the present studies together with past findings demonstrate the critical importance of the active site catalytic serine residue of the proteinase in the formation of high affinity covalent complexes with serpins. This characteristic feature of the interactions of serpin family inhibitors with their target proteinases sets them apart from the nonserpin protein proteinase inhibitors, which are known to form tight noncovalent complexes with both active proteinases and catalytically inactive anhydroproteinases (40, 41). Our observations thus support the growing body of evidence that the inhibitory mechanism of serpins differs fundamentally from that of the nonserpin protein proteinase inhibitors. Indeed, a consensus view that has been developing is that serpins behave as suicide inhibitors, i.e. they are activated by proteinase-mediated cleavage of the serpin as a normal substrate to trap their target proteinases through a major serpin conformational change (2).


FOOTNOTES

*   This work was supported in part by National Institutes of Health Grants HL-39888 (to S. T. O.) and HL-49242 (to P. A. P.) and by Swedish Medical Research Council Grant 4212 and EU Biomed 2 Grant BM H4-CT96-0937 (to I. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom correspondence should be addressed: Center for Molecular Biology of Oral Diseases, Rm. 530E, Dentistry (m/c 860), University of Illinois, 801 S. Paulina St., Chicago, IL 60612. Tel.: 312-996-1043; Fax: 312-413-1604.
1   The abbreviations used are: DCI, 3,4-dichloroisocoumarin; HNE, human neutrophil elastase; alpha 1PI, alpha 1-proteinase inhibitor; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine.

REFERENCES

  1. Potempa, J., Korzus, E., and Travis, J. (1994) J. Biol. Chem. 269, 15957-15960 [Free Full Text]
  2. Gettins, P. G. W., Patston, P. A., and Olson, S. T. (1996) Serpins: Structure, Function, and Biology, R. G. Landes Co., Austin, TX
  3. Laskowski, M., Jr., and Kato, I. (1980) Annu. Rev. Biochem. 49, 593-626 [CrossRef][Medline] [Order article via Infotrieve]
  4. Bode, W., and Huber, R. (1992) Eur. J. Biochem. 204, 433-451 [Abstract]
  5. Rosenberg, R. D., and Damus, P. S. (1973) J. Biol. Chem. 248, 6490-6505 [Abstract/Free Full Text]
  6. Moroi, M., and Yamasaki, M. (1974) Biochim. Biophys. Acta 359, 130-141 [Medline] [Order article via Infotrieve]
  7. Moroi, M., and Aoki, N. (1977) Biochim. Biophys. Acta 482, 412-420 [Medline] [Order article via Infotrieve]
  8. Wiman, B., and Collen, D. (1979) J. Biol. Chem. 254, 9291-9297 [Medline] [Order article via Infotrieve]
  9. Olson, S. T., Bock, P. E., Kvassman, J., Shore, J. D., Lawrence, D. A., Ginsburg, D., and Björk, I. (1995) J. Biol. Chem. 270, 30007-30017 [Abstract/Free Full Text]
  10. Engh, R. A., Wright, H. T., and Huber, R. (1990) Protein Eng. 3, 469-477 [Abstract]
  11. Schulze, A. J., Baumann, U., Knof, S., Jaeger, E., Huber, R., and Laurell, C. B. (1990) Eur. J. Biochem. 194, 51-56 [Abstract]
  12. Skriver, K., Wikoff, W. R., Patston, P. A., Tausk, F., Schapira, M., Kaplan, A. P., and Bock, S. C. (1991) J. Biol. Chem. 266, 9216-9221 [Abstract/Free Full Text]
  13. Carrell, R. W., Evans, D. L., and Stein, P. E. (1991) Nature 353, 576-578 [CrossRef][Medline] [Order article via Infotrieve]
  14. Björk, I., Ylinenjärvi, K., Olson, S. T., and Bock, P. E. (1992) J. Biol. Chem. 267, 1976-1982 [Abstract/Free Full Text]
  15. Björk, I., Nordling, K., and Olson, S. T. (1993) Biochemistry 32, 6501-6505 [Medline] [Order article via Infotrieve]
  16. Morii, M., Odani, S., and Ikenaka, T. (1979) J. Biochem. (Tokyo) 86, 915-921 [Abstract]
  17. Nilsson, T., and Wiman, B. (1982) FEBS Lett. 142, 111-114 [CrossRef][Medline] [Order article via Infotrieve]
  18. Ferguson, W. S., and Finlay, T. H. (1983) Arch. Biochem. Biophys. 220, 301-308 [Medline] [Order article via Infotrieve]
  19. Matheson, N. R., van Halbeek, H., and Travis, J. (1991) J. Biol. Chem. 266, 13489-13491 [Abstract/Free Full Text]
  20. Lawrence, D. A., Ginsburg, D., Day, D. E., Berkenpas, M. B., Verhamme, I. M., Kvassman, J., and Shore, J. D. (1995) J. Biol. Chem. 270, 25309-25312 [Abstract/Free Full Text]
  21. Wilczynska, M., Fa, M., Ohlsson, P., and Ny, T. (1995) J. Biol. Chem. 270, 29652-29655 [Abstract/Free Full Text]
  22. Strömqvist, M., Karlsson, K.-E., Björquist, P., Andersson, J.-O., Byström, M., Hansson, L., Johansson, T., and Deinum, J. (1996) Biochim. Biophys. Acta 1295, 103-109 [Medline] [Order article via Infotrieve]
  23. Christensen, S., Valnickova, Z., Thøgersen, I. B., Pizzo, S. V., Nielsen, H. R., Roepstorff, P., and Enghild, J. J. (1995) J. Biol. Chem. 270, 14859-14862 [Abstract/Free Full Text]
  24. Cohen, A. B. (1973) J. Biol. Chem. 248, 7055-7059 [Abstract/Free Full Text]
  25. Moroi, M., Yamasaki, M., and Aoki, N. (1975) J. Biochem. (Tokyo) 78, 925-928 [Abstract]
  26. Glaser, C. B., Bridrick, J. W., Drechsel, D., Karic, L., Graceffo, M., and Largman, C. (1982) Biochemistry 21, 556-561 [Medline] [Order article via Infotrieve]
  27. Lijnen, H. R., Van Hoef, B., and Collen, D. (1991) J. Biol. Chem. 266, 4041-4044 [Abstract/Free Full Text]
  28. Yung, B. Y. K., and Trowbridge, C. G. (1980) J. Biol. Chem. 255, 9724-9730 [Abstract/Free Full Text]
  29. Melhado, L. L., Peltz, S. W., Leytus, S. P., and Mangel, W. F. (1982) J. Am. Chem. Soc. 104, 7299-7306
  30. Robinson, N. C., Tye, R. W., Neurath, H., and Walsh, K. A. (1971) Biochemistry 10, 2743-2747 [Medline] [Order article via Infotrieve]
  31. Bloom, J. W., and Hunter, M. J. (1978) J. Biol. Chem. 253, 547-589 [Abstract]
  32. Harper, J. W., Hemmi, K., and Powers, J. C. (1985) Biochemistry 24, 1831-1841 [Medline] [Order article via Infotrieve]
  33. Olson, S. T., Björk, I., and Shore, J. D. (1993) Methods Enzymol. 222, 525-560 [Medline] [Order article via Infotrieve]
  34. Tian, W. X., and Tsou, C. L. (1982) Biochemistry 21, 1028-1032 [Medline] [Order article via Infotrieve]
  35. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  36. Schägger, H., and von Jagow, G. (1987) Anal. Biochem. 166, 368-379 [Medline] [Order article via Infotrieve]
  37. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354 [Abstract]
  38. Björk, I., Jackson, C. M., Jörnvall, H., Lavine, K. K., Nordling, K., and Salsgiver, W. J. (1982) J. Biol. Chem. 257, 2406-2411 [Abstract/Free Full Text]
  39. Enghild, J. J., Valnickova, Z., Thogersen, I. B., and Pizzo, S. V. (1994) J. Biol. Chem. 269, 20159-20166 [Abstract/Free Full Text]
  40. Ako, H., Foster, R. J., and Ryan, C. A. (1974) Biochemistry 13, 132-139 [Medline] [Order article via Infotrieve]
  41. Vincent, J., Peron-Renner, M., Pudles, J., and Lazdunski, M. (1974) Biochemistry 13, 4205-4211 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.